Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06581887

Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University College, London · Academic / Other
Sex
Male
Age
7 Years – 17 Years
Healthy volunteers
Accepted

Summary

Study aims to develop and to evaluate the neurophysiological and physiological response to a classical conditioning task.To better understand how Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) impacts mental health and how to assess it. Participants invited to complete questionnaires about behaviour, cognitive function and social interactions, complete computer tasks and have an optional MRI brain scan,

Detailed description

The investigation aims to develop and to evaluate the neurophysiological and physiological response to a classical conditioning task, which is comparable to findings that have been made in the mdx dystrophic mouse (deficient in Dp427). The investigators will assess correlations between the specific DMD/BMD genotype and susceptibility to conditioning, as well as the relationship between conditioning and behavioural/emotional characteristics of the syndrome. At the end of the study, the objective is to deliver a comprehensive test battery that is suitable for use in a trial of AON delivery to improve brain function.

Conditions

Interventions

TypeNameDescription
BEHAVIORALClassical conditioning taskTo evaluate the neurophysiological and physiological response to a classical conditioning task, which is comparable to findings that have been made in the mdx dystrophic mouse (deficient in Dp427). The investigators will assess correlations between the specific DMD/BMD genotype and susceptibility to conditioning, as well as the relationship between conditioning and behavioural/emotional characteristics of the syndrome.

Timeline

Start date
2022-09-13
Primary completion
2024-11-19
Completion
2024-12-31
First posted
2024-09-03
Last updated
2024-09-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06581887. Inclusion in this directory is not an endorsement.